GSK narrows focus on elderly in trial to treat pneumonia from COVID-19 – Reuters

GSK narrows focus on elderly in trial to treat pneumonia from COVID-19 – Reuters

GlaxoSmithKline will extend a trial testing an experimental rheumatoid arthritis drug on patients suffering from pneumonia related to COVID-19 to focus on the elderly as it seeks to firm up encouraging findings so far.

Read More…

You May Also Like